Class II · Moderate risk
Hair Back
CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.
FDA Drug Recalls
1,356 recalls, newest first
Class II · Moderate risk
Glauco-Catar Capsules
CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.
Class II · Moderate risk
Fungo Balm
CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.
Class II · Moderate risk
Edema Off Capsules
CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.
Class II · Moderate risk
Dragon Pain Oil
CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.
Class II · Moderate risk
Dragon Pain Balm
CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.
Class II · Moderate risk
Deafness Off Capsules
CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.
Class II · Moderate risk
Cardia Forte
CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.
Class II · Moderate risk
Bone Fixer
CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.
Class II · Moderate risk
Baby Saver Capsules
CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.
Class II · Moderate risk
Awake
CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.
Class II · Moderate risk
Asthma Balm 60 gram
CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.
Class II · Moderate risk
Asma Aid Distributed by Herbal Doctor Remedies Alhambra
CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.
Class II · Moderate risk
Neomycin 3.5 mg/g / Polymyxin B10000 USP Units/g / Dexamethasone…
CGMPs Deviations: Insufficient Quality Assurance controls over critical systems in the manufacturing facility.
Class II · Moderate risk
Sn-Pyrophosphate Kit
Lack of Processing Controls.
Class II · Moderate risk
Sn-Tetrofosmin Kit 5.0 mL
Lack of Processing Controls.
Class II · Moderate risk
Sn-DTPA Kit 10 mg
Lack of Processing Controls.
Class II · Moderate risk
Sn-d
Lack of Processing Controls.
Class II · Moderate risk
Sulfur Colloid Reaction Vial 1.0 mL
Lack of Processing Controls.
Class II · Moderate risk
Sn-Mertiatide Kit
Lack of Processing Controls.
Class II · Moderate risk
Sn-DMSA solution
Lack of Processing Controls.
Class II · Moderate risk
Pentreotide
Lack of Processing Controls.
Class II · Moderate risk
Unison Hand Care Products
CGMP Deviations: hand sanitizers and soaps were not produced under current good manufacturing practices.
Class II · Moderate risk
Antibacterial Hand Soap
CGMP Deviations: hand sanitizers and soaps were not produced under current good manufacturing practices.
Class II · Moderate risk
Sani-Guard-SF Waterless Foam Hand Sanitizer
CGMP Deviations: hand sanitizers and soaps were not produced under current good manufacturing practices.